contractions, rabbits were administered aspirin (20 mg/kg) for 2 days On day 4, methachohneinduced contractions of pulmonary arteries were depressed m aspmn-treated compared with control subjects Control arteries synthesized 6-keto-prostaglandm F,, and TXB? Aspmn treatment inhibited both pulmonary artery and platelet TXB, production but had no effect on vessel 6-keto-prostaglandm F,, These studies unphcate platelets as a vascular source of TXA, and indicate that both endothehal cells and platelets may be reqmred for methachohne-induced TXA, synthesis and vasoconstrlctlon (Hypertension. 1998;31[part2]:206-212.) Key Words: thromboxane A2 n cyclooxygenase n platelets n arachldomc acid w endothehal cells n endothehum-derived contracting factor
Abstract-Arachldomc acid-and methachohne-induced contractions of rabbit pulmonary arteries are mediated by thromboxane (TX) A, Although removal of the endothehum abolishes the contractions, endothehal cells isolated from pulmonary arteries do not synthesize TXA, Further studies described here showed that the expression of TX synthase was evident m platelets and intact pulmonary artery but not m endothehal cells These studies examined the role of platelet TXA2 production m the vasoconstrlctor response to methacholme Endothehal cells were incubated with platelets m the presence or absence of methachohne Methacholme caused an increase m TXB, production Pretreatment of endothehal cell? with aspmn (100 pmol/L) before the addition of platelets did not impair the ability of methachohne to Increase TXB, synthesis Conversely, if platelets were pretreated with aspirin, methachohne failed to stimulate TXB, However, pretreatment of the endothehal cells with aspirin did not affect the ability of methachohne to induce [3H] TXBz release This suggests that methacholme stimulated the endothehal cell to release arachldomc acid, which was transferred to the platelets and metabolized to TXA, To test whether this cell-cell mteractlon 1s necessary for methachohne-induced contractions, rabbits were administered aspirin (20 mg/kg) for 2 days On day 4, methachohneinduced contractions of pulmonary arteries were depressed m aspmn-treated compared with control subjects Control arteries synthesized 6-keto-prostaglandm F,, and TXB? Aspmn treatment inhibited both pulmonary artery and platelet TXB, production but had no effect on vessel 6-keto-prostaglandm F,, These studies unphcate platelets as a vascular source of TXA, and indicate that both endothehal cells and platelets may be reqmred for methachohne-induced TXA, synthesis and vasoconstrlctlon (Hypertension. 1998; 31[part2]:206-212.) Key Words: thromboxane A2 n cyclooxygenase n platelets n arachldomc acid w endothehal cells n endothehum-derived contracting factor I n recent years, the importance of various factors synthesized and released from the blood vessel endothehum that contribute to the regulation of vascular tone has become apparent In pulmonary vessels, we have identified an endothehumderived contracting factor as thromboxane (TX) A,' The control of pulmonary vascular resistance mvolves the mteractlon of various vasoconstnctors, such as TXA,, and vasodllators, such as prostacyclm Because both prostacyclm and TXA, are cyclooxygenase metabohtes of arachldomc acid, it IS postulated that a balance m these two compounds contributes to the regulation of vascular tone Abnormahtles m the balance of these factors may then have a role m certain pathological states For example, an increased synthesis of TXA2 1s assoclated with pulmonary disease,'-" and TXA? has been shown to be involved m pulmonary vasoconstrlctlon observed m a number of animal models of pulmonary hypertension i-x
The major source of TXA2 1s the platelet, polymorphonuclear leukocyte (PMN), and monocyte +" Although there are numerous reports of TXA? production by blood vessels,'" " " there 1s still controversy as to whether endothehal cells synthesize TXA2 Several researchers have reported that cultured endothehal cells produce not only prostacyclm but also TX& 'G" In contrast, we and others have failed to detect TXB2 synthesis by endothehal cells '~"~*' Cultured rabbit pulmonary arterial endothehal cells synthesized 6-keto-prostaglandm (PG) F,,, the stable metabohte of prostacyclm, but not TXB2 ' Immunohlstochcmlcal studies indicated the presence of cyclooxygenase, but not TX synthase, m pulmonary artery endothehal cells Campbell and coworkers'" reported that primary cultures of umblhcal endothehal cells produced TXB? However, when the cells were passaged, TXB, production wa5 lost The synthesis of TXE$ m the pnmary cultures was PJster et al 207 Selected Abbrewations and Acronyms PG = prostaglandm I'MN = polymorphonuclear leukocyte RIA = radmunmunoassay RP-HPLC = reverse-phase h&pressure hquld chromatography TX = thromboxane associated with adherent platelets With passage, adherent platelets were lost, as was TXB2 synthesis Because it IS important to identify the cellular source of TXA, m pulmonary vessels to assess its role m pulmonary function, the present study was designed to test the hypothesis that TXA, synthesis by intact pulmonary arteries requires an mteractlon between the endothehal cells and adherent platelets Additional experiments are described that use aspmn-treated rabbits to study the role of the platelet m the vasoconstrlctor response to arachldome acid and methacholme m the intact pulmonary artery 
Results
Using a specific polyclonal anti-TX synthase antibody, Western blot analyslr showed the presence of mmunoreactwe bands m lycates prepared from rabbit platelets and rabbit pulmonary arteries (Fig 1) . These bands corresponded to the 60-kDa TX cynthace protem ."I " Human platelet rmcro~ornec enriched m TX synthase were mcluded ac a posltlve control. In pulmonary endothehal cells, the presence of TX synthase was not de- tected. This experiment mar repeated 3 times, and similal results were observed.
We determined whether platelets synthesized TXB? in response to methacholine. When platelets were incubated with varying concentrations of methacholine, we failed to detect any stimulation of TXB? synthesis by RIA (data not shown). In contrast, arachidonic acid caused a concentration-related increase in TXB? synthesis by platelets (data not shown). To determine whether the production of TXBz by intact pulmonary artery required an interaction between endothelial cells and adherent platelets, endothelial cells and platelets mere incubated as described under Methods. As shown previously, endothelial cells alone did not produce TXB? under either basal (Table 1) or methacholine-stimulated conditions.' In the presence of endothelial cells and platelets, TXBl \vas enhanced approximately 2-fold by the addition of methacholine (Table  1) . Because aspirin irreversibly inactivates cyclooxygenase, it was used as a tool to investigate the interaction between these cells. Results showed that when endothelial cells were coincubated with aspirin-treated platelets, methacholine failed to induce TXB? synthesis (Table 1) . I n contrast, when aspiriiitreated endothelial cells were coincubated with platelets, methacholine-induced TXB? production was not impaired (Table 1) . The production of 6-keto-PGF,, was measured in the coincubation studies (Table 1 ). The addition of platelets to endothelial cells did not alter the production of 6-keto-PGF,,. If the endothelial cells were pretreated with aspirin, &keto-PGF,, production decreased (data not shown). In the presence of nornlal platelets, aspirin-treated endothelial cell production of 6-keto-PGF,,, was still attenuated (Table 1) .
These studies were confirmed with ['Hlarachidonic acid and the results shown in Fig 2. In radiolabeled endothelial cells incubated with methacholine (19 ' mol/L), there was no production of ['H]TXB, (Fig 2A) . When the endothelial cells were incubated with methacholine in the presence of control platelets, vH]TXBZ was a major synthetic product (Fig 2B) . If aspirin-treated platelets were added to normal endothelial cells, methacholine failed to stimulate the production of [JH]TXB? (Fig 2C) . In contrast, aspirin pretreatment of endothelial cells blocked the production of the cyclooxygenase products 6-ke- Fraction to-PGF,, and -PGE*, however, pretreatment of the endotheha1 cells with aspmn did not affect the ability of methacholme to Induce TXB2 release m the presence of normal platelets ( Fig  2D) . The production of [3H]6-keto-PGF,0 by endothehal cells was not affected by the addition ofplatelets (Fig 2B) When the endothehal cells were pretreated with aspmn and comcubated with normal platelets, no production of [3H]6-keto-PGF,, was observed (Fig 2D) The next series of expenments was designed to use aspmntreated rabbits to further study the role of platelets m the vasoconstnctor response to arachldomc acid and methachohne m the mtact pulmonary artery Arachldomc acid and methachohne produced concentration-related contractions m the control rabbits (Fig 3) However, m the rabbits treated with the highest dose of aspmn (20 mg/kg), there was a slgmficant attenuation of both arachldomc acid-(maximal contraction 66 125 4% versus 15 2?3 8%, control versus aspmn-treated, P< 05) and methachohne-(maximal contraction 55 4+5 8% versus 16 324 0%, control versus aspmn-treated, P< 05) induced contractions (Fig  3) The vasoconstnctor response to the TX-rmmetlc U46619 was the same m the control and high-dose aspmn-treated animals (data not shown) To assess cyclooxygenase mhlbltlon, pulmonary artenes and platelets f?om the control and aspmn-treated rabbits were incubated wth ['4C]arachldonlc acid and extracted metabohtes analyzed by RP-HPLC Both control (Fig 4A) and highdose aspmn-treated (Fig 4B) pulmonary artenes synthesized [14C]6-keto-PGF,,, however, its synthesis was less m the vessels from the aspmn-treated rabbits When measured by RIA, it also seemed that 6-keto-PGF,,, production was reduced m the aspmntreated rabbit pulmonary arteries (Table 2 ) High-dose aspmn treatment inhibited the production of [14C]TXB, (Fig 4B) By HPLC analysis, TXB2 production was 45 3?18 cps/mg for the control pulmonary artenes and 23 028 cps/mg tissue for the aspmn-treated pulmonary artenes When measured by RIA, there was an approximate 60% reducnon in TXB, production m the pulmonary artenes obtamed from aspmn-treated rabbits com- (Table 2 ) Likewise, m the platelets from the high-dose aspmn-treated rabbits, [14C]TXB, production was depressed compared with control rabbits (Fig 4C and 4D ) Because 6-keto-PGF,, production was lower m the high-dose aspmn-treated rabbits compared with control rabbits, addmona experiments were performed m which rabbltc were treated with lower doses of aspmn The vascular reactlvlty responses to methachohne m rabbits admnustered the low-dose regunen (5 mg/kg, PO) or the medmm-dose regmen (10 mg/kg, PO) 1s shown m Fig 3 (bottom) The lower dose of aspmn did not reduce the contractile response to methachohne compared wth the control rabbits, whereas the medium dose produced an approximate 50% reduction m methachohne-induced contractions The low-dose acpmn treatment did not alter either the pulmonary artery or platelet production of ["C]TXE$ compared with the control rabbits (data not shown) In pulmonary artenes obtamed from rabbits treated with the 10 mg/kg dose of aspmn, ['%]6-keto-PGF,, production was clmllar when compared wth the control rabbits (Fig 5) , however, the platelet ["CJTXB, production was decreased m the treated rabbits compared with the control rabbits Segments of pulmonary arteries from control or aspirin-treated rabbits were incubated with vehicle or arachidomc acid (AA) (IOF mol/L) for 15 minutes at 37°C Production of 6-keto-PGF,, and TXE$ were measured in the mcubation media by radioimmunoassay Values are the mean?SEM for n=6 vessel segments PJister et al HPLC, KIA, and gas chromatography/mass spectrometry analysis, our previous work conclusively showed that TXA, 1s the mediator of these contractlons However, the question remained 3s to which cell type(s) m the intact pulmonary artery produce TXA, Although there are numerous reports of TXAz production by blood vessels,'"" I3 controversy exists as to whether endothehal cells synthesize TXA2 Some researchers have reported that cultured endothehal cells produce not only prostacyclm but also TXA2 ",'5 In contrast, other studies did not detect TXA, synthesis by endothehal cells "-" In our previous study,' unmunofluorescence of rabbit pulmonary endothehal cells faded to detect the presence of TX synthase, whereas the presence of cyclooxygenase was clearly shown The present study further supported the absence of TX synthase m cultured rabbit pulmonary artery endothehal cells Using a specific polyclonal anti-TX synthase antibody, Western blot analysis showed the presence oflmmunoreactlve bands m lysates prepared from rabbit platelets and intact rabbit pulmonary artery These bands corresponded to the 60-kD TX synthase protem purified from human platelets3'lm3* and comigrated with a human platelet mlcrosome emlched m TX synthase However, m lysates prepared from the rabbit pulmonary artery endothehal cells, no lmmunoreactlve band was observed Our previous expenments also showed that endothehal cells incubated with
When a more sensmve RIA method was used to quantltate TXB2 production under both basal and stimulated condltlons, no detectable TX& was measured Taken collectively, these studies would be consistent with some cell type other than endothehal cells releaymg TXA2 Because TXA, 1s the major arachldomc acid metabohte m platelets, we tested the hypothesis that TXA, synthesis by intact pulmonary arteries requires an interaction between endothehal cells and platelets
We showed that methacholme stimulated TXB, synthesis m intact pulmonary artery ' However, incubation of platelets with methachohne does not stimulate TXB2 production, and cholmergc receptors have not been reported to emst on platelets Therefore, a question remains as to how methachohne enhances the release of TXA, corn the platelet in the intact pulmonary artery PGH, from stimulated platelets may be taken up by endothehal cells and used to produce PGI?, however, this transfer of PGH2 does not operate m the reverse direction, le, platelets do not take up PGH, from endothehal cells for TXA, synthesis l7 ") It 1s possible that endothehal cells ti, however, transfer arachldonlc acid to platelets and promote TXB2 synthesis We investigated this interaction in cultured endothehal cells and platelets dunng methachohne stnnulatlon Methachohne stimulated TXB, synthesis m platelets and endothehal cells but not in platelets alone or m endothehal cells alone, supporting our hypotheqls that an mteractlon between these two cell types 1s required for methacholine-Induced TXA2 synthesis Additional expenments used aspmn as a tool to confirm that arachldotuc acid and not the cyclooxygenase metabollte PGH2 was transferred to the platelet and further metabohzed to TXA, Aspmn meverslbly inactivates cyclooxygenase by acetylatlng the enzyme " Pretreatment of plateleb with aspmn blocks mcthachohne-Induced The last senes of experiments used asptnn-treated rabbits to study the role of the platelet tn the vasoconstnctor response to arachldornc actd and methachollne tn the intact pulmonary artery It has been documented that aspmn can 5eleLtlvely mhlblt platelet cyclooxygenase becduse of the tnab&y of platelets to regenerate their cyclooxygenase Thus, asptnn has a longer duration of action in platelets than m endothehal cells 39 This treatment regnnen was designed to selectively tnhlblt platelet, but not endothehal, cycleoxygenase In rabbits tlcated wtth high and medium doses of aspmn, platelet and pulmonary artery ['"C]TXI3, synthesis wa\ tnhlblted Pulmonary artery ploductlon of , ~~15 reduced m the high-dose aspmn-treated lAbbits compared with the control rabbit\ However, at the lower doses of aspmn, pulmonary artery 6-keto-PGF,, productlon was smular between the treated and control Iabbtts The vdsoConstnc.tor responses to methachohne and ardchldotnc acid wele reduced m vessels from the medtutn-and high-dose aspmn-treated labbits but not m the vessels from control rdbblty or m rabbits treated with the low-dose arpmn regmen The tesponse to U46619 was the same tn the vescels from control and aspmn-treated annnals Because platelet TXA, production 1\ decreased In the aspmn-treated ldbblts that exhtbtted decteased contrdctlle re5pome to methacholme, these results would niiphcdte platelets '1s the cellular soLme of TXA, productton It is impoitatit to note thdt d Lecent repott by Udrry et 212 Platelet-Derived Thromboxane and Pulmonary Artery Contractions al35 has shown that rmcropartlcles released from platelets also play a role m the transcellular metabohsm of arachldomc acid Speclflcally, platelet rmcropamcles were shown to transfer arachldomc acid to the platelets to be used for TXA, synthesis Although this mechanism was not explored m the present study, it gwes fimher support for how platelets can mfluence vascular fincnon Although the major source of TXA, IS the platelet, PMN and monocyte also produce TXA19-" Therefore, PMNs or monocytes may also be possible sources of TX synthase m the rabbit pulmonary artery Because this potential mechanism was not examined m the present study, the role of PMNs and monocytes cannot be eliminated Therefore, we propose that methachohne-induced contractions of rabbit pulmonary artery are mediated by the release of arachldomc acid from endothehal cells and its transfer to adherent platelets that subsequently synthesize the contracting factor TXAz TXA, IS released by the platelet and has a direct effect on vascular smooth muscle TXA2 receptors These studies support the concept of transcellular metabolism of arachldomc acid m the pulmonary vasculature Because TXA, IS an important mediator of pulmonary hypertension caused by a vanety of pathophyslologlcal condltlons,'-* the identity of the platelet, and not the endothehum, as a cellular source of TXA, may provide further insight into the role of platelets m the regulation of pulmonary vascular tone
